Details of the Drug

General Information of Drug (ID: DMB0CXT)

Drug Name
GSK2330811
Indication
Disease Entry ICD 11 Status REF
Crohn disease DD70 Phase 2 [1]
Systemic sclerosis 4A42 Phase 2 [2]
Cross-matching ID
TTD ID
D0D3TQ
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Oncostatin-M (OSM) TTIVXSE ONCM_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04151225) Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease (COSMIS). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)